Could a heart drug save brain function after a devastating stroke?
NCT ID NCT04362527
First seen Oct 31, 2025 · Last updated Jun 11, 2026 · Updated 35 times
Summary
This study tested whether a medicine called milrinone, given through a vein, can help people recover better from a serious type of stroke called subarachnoid hemorrhage. After this stroke, many patients develop dangerous spasms in brain arteries that can cause further brain damage. The trial involved 370 adults with this condition and compared milrinone to a placebo to see if it improves recovery at 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOSPASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP Lariboisière
Paris, France
-
CHU Angers
Angers, France
-
CHU Besançon
Besançon, France
-
CHU Bordeaux
Bordeaux, France
-
CHU Brest
Brest, France
-
CHU Caen
Caen, France
-
CHU Dijon
Dijon, France
-
CHU Lille
Lille, France
-
CHU Nantes
Nantes, France
-
CHU Rennes
Rennes, France
-
CHU Tours
Tours, France
-
Hôpital Civils de Lyon
Lyon, France
-
Hôpital Fondation ROTHSCHILD
Paris, France
-
Hôpital Gabriel Montpied
Clermont-Ferrand, France
-
Hôpital Gui de Chauliac
Montpellier, France
-
Hôpital de Hautepierre
Strasbourg, 67098, France
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.